nach oben

NeuroMolecular Medicine

Erschienen in:

18.10.2019 | Original Paper

Is 1,8-Cineole-Rich Extract of Small Cardamom Seeds More Effective in Preventing Alzheimer’s Disease than 1,8-Cineole Alone?

verfasst von: Kaninika Paul, Upasana Ganguly, Sasanka Chakrabarti, Paramita Bhattacharjee

Erschienen in: NeuroMolecular Medicine | Ausgabe 1/2020

Einloggen, um Zugang zu erhalten

Abstract

The present study demonstrates the efficacies of synthetic 1,8-cineole and an 1,8-cineole-rich supercritical carbon dioxide (SC-CO₂) extract of small cardamom seeds in preventing oligomerization of amyloid beta peptide (Aβ42) and inhibiting iron-dependent oxyradical production in vitro. The oligomerization of Aβ42 was monitored by thioflavin T assay and MALDI-TOF analysis of the oligomers. The iron-dependent production of oxygen free radicals was detected by fluorometric benzoate hydroxylation assay. We observed that both pure 1,8-cineole and 1,8-cineole-rich extract of small cardamom seeds at concentrations of 50 µM and 100 µM prevented the production of reactive hydroxyl radicals from a mixture of Fe²⁺ and ascorbate. However, the 1,8-cineole-rich extract of small cardamom seeds prevented in vitro Aβ42 oligomerization more effectively vis-à-vis the synthetic (99% pure) 1,8-cineole. Additional study on SHSY5Y cells indicated that both pure 1,8-cineole and 1,8-cineole-rich SC-CO₂ extract of small cardamom seeds prevented iron-dependent cell death. Since oxidative damage, Aβ42 aggregation and loss of cell viability (iron-induced) are characteristics of onset of Alzheimer’s disease pathology, our results suggest a putative therapeutic role of 1,8-cineole-rich extract of small cardamom seeds over pure 1,8-cineole in preventing this neurodegenerative disease.

Adams, R. P. (2007). Identification of essential oil components by gas chromatography/mass spectroscopy (3rd ed.). Carol Stream, IL: Allured Publishing Corporation.

Banerjee, P., Sahoo, A., Anand, S., Ganguly, A., Righi, G., Bovicelli, P., et al. (2014). Multiple mechanisms of iron-induced amyloid beta-peptide accumulation in SHSY5Y cells: Protective action of negletein. NeuroMolecular Medicine,16(4), 787–798. https://doi.org/10.1007/s12017-014-8328-4.CrossRefPubMed

Barile, F. B. (2013). Cell culture methods for acute toxicology testing. In F. B. Barile (Ed.), Principles of toxicology testing (2 ed., p. 192). Boca Raton: CRC Press.CrossRef

Bartolini, M., Naldi, M., Fiori, J., Valle, F., Biscarini, F., Nicolau, D. V., et al. (2011). Kinetic characterization of amyloid-beta 1–42 aggregation with a multimethodological approach. Analytical Biochemistry,414(2), 215–225. https://doi.org/10.1016/j.ab.2011.03.020.CrossRefPubMed

Caldas, G. F., Limeira, M. M., Araújo, A. V., Albuquerque, G. S., Silva-Neto, J. D., Silva, T. G., et al. (2016). Repeated-doses and reproductive toxicity studies of the monoterpene 1,8-cineole (eucalyptol) in Wistar rats. Food and Chemical Toxicology,97, 297–306. https://doi.org/10.1016/j.fct.2016.09.020.CrossRefPubMed

Chakraborty, H., Ray, S. N., & Chakrabarti, S. (2001). Lipid peroxidation associated protein damage in rat brain crude synaptosomal fraction mediated by iron and ascorbate. Neurochemistry International,39, 311–317. https://doi.org/10.1016/S0197-0186(00)00117-0.CrossRefPubMed

Chen, Z., & Zhong, C. (2013). Decoding Alzheimer’s disease from perturbed cerebral glucose metabolism: Implications for diagnostic and therapeutic strategies. Progress in Neurobiology,108, 21–43. https://doi.org/10.1016/j.pneurobio.2013.06.004.CrossRefPubMed

Cummings, J., Morstorfb, T., & Lee, G. (2016). Alzheimer’s drug-development pipeline: 2016. Alzheimer’s & Dementia,2(4), 222–232. https://doi.org/10.1016/j.trci.2016.07.001.CrossRef

Galimberti, D., & Scarpini, E. (2011). Disease-modifying treatments for Alzheimer’s disease. Therapeutic Advances in Neurological Disorder,4(4), 203–216. https://doi.org/10.1177/1756285611404470.CrossRef

Ganguly, G., Chakrabarti, S., Chatterjee, U., & Saso, L. (2017). Proteinopathy, oxidative stress and mitochondrial dysfunction: cross talk in Alzheimer’s disease and Parkinson’s disease. Drug Design, Development and Therapy,11, 797–810. https://doi.org/10.2147/DDDT.S130514.CrossRefPubMedPubMedCentral

Ganguly, U., Ganguly, A., Sen, O., Ganguly, G., Cappai, R., Sahoo, A., et al. (2019). Dopamine Cytotoxicity on SH-SY5Y Cells: Involvement of α-Synuclein and relevance in the neurodegeneration of sporadic Parkinson’s disease. Neurotoxicity Research,35(4), 898–907. https://doi.org/10.1007/s12640-019-0001-0.CrossRefPubMed

Ghosh, S., Bhattacharjee, P., & Das, S. (2015). 1,8-Cineol-rich cardamom seed (Elettaria cardamomum) extracts using green technologies and conventional extractions: Process analysis, phytochemical characterization and food application. Separation Science and Technology,50(13), 1974–1985. https://doi.org/10.1080/01496395.2015.1016038.CrossRef

Gratuze, M., Leyns, C. E. G., & Holtzman, D. M. (2018). New insights into the role of TREM2 in Alzheimer’s disease. Molecular Neurodegeneration,13(1), 1–16. https://doi.org/10.1186/s13024-018-0298-9.CrossRef

Habtemariam, S. (2018). Iridoids and other monoterpenes in the Alzheimer’s brain: Recent development and future prospects. Molecules,23(117), 1–23. https://doi.org/10.3390/molecules23010117.CrossRef

Held, S., Schieberle, P., & Somoza, V. (2007). Characterization of α-Terpineol as an anti-inflammatory component of orange juice by in vitro studies using oral buccal cells. Journal of Agricultural and Food Chemistry,55(20), 8040–8046. https://doi.org/10.1021/jf071691m.CrossRefPubMed

Jana, S., Sinha, M., Chanda, D., Roy, T., Banerjee, K., & Munshi, S. (2011). Mitochondrial dysfunction mediated by quinone oxidation products of dopamine: Implications in dopamine cytotoxicity and pathogenesis of Parkinson’s disease. Biochimica et Biophysica Acta,1812(6), 663–673. https://doi.org/10.1016/j.bbadis.2011.02.013.CrossRefPubMed

Jiang, T., Yu, J. T., & Tan, L. (2012). Novel disease-modifying therapies for Alzheimer’s disease. Journal of Alzheimer’s Disease,31(3), 475–492. https://doi.org/10.3233/JAD-2012-120640.CrossRefPubMed

Kundu, A., & Mitra, A. (2013). Flavoring extracts of Hemidesmus indicus roots and Vanilla planifolia pods exhibit in vitro acetylcholinesterase inhibitory activities. Plant Foods for Human Nutrition,68(3), 247–253. https://doi.org/10.1007/s11130-013-0363-z.CrossRefPubMed

Kuyumcu, E., & Küçükba, F. Z. (2013). Essential oil composition of Elettaria cardamomum Maton. Journal of Applied Biological Sciences,7(3), 42–45.

Lee, J., Kim, M., & Park, S. (2017). Effect of natural antioxidants on the aggregation and disaggregation of beta-amyloid. Tropical Journal of Pharmaceutical Research,16(11), 2629–2635. https://doi.org/10.4314/tjpr.v16i11.9.CrossRef

Lima, M. H. (2004). Oxygen in biology and biochemistry: Role of free radicals. In K. B. Storey (Ed.), Functional metabolism: regulation and adaptation (p. 326). New Jersey: Wiley.

Long, J. M., Maloney, B., Rogers, J. T., & Lahiri, D. K. (2019). Novel upregulation of amyloid-β precursor protein (APP) by microRNA-346 via targeting of APP mRNA 5′-untranslated region: Implications in Alzheimer’s disease. Molecular Psychiatry,24(3), 345–363. https://doi.org/10.1038/s41380-018-0266-3.CrossRefPubMed

Maria, S. G. A., Edison, O., & Patricia, C. G. G. (2016). Linalool reverses neuropathological and behavioral impairments in old triple transgenic Alzheimer’s mice. Neuropharmacology,102, 111–120. https://doi.org/10.1016/j.neuropharm.2015.11.002.CrossRef

Obulesu, M., & Rao, D. M. (2011). Effect of plant extracts on Alzheimer’s disease: An insight into therapeutic avenues. Journal of Neurosciences in Rural Practice,2(1), 56–61. https://doi.org/10.4103/0976-3147.80102.CrossRefPubMedPubMedCentral

Patterson, C. (2018). World Alzheimer Report 2018. The state of the art of dementia research: New frontiers. Alzheimer’s Disease International (ADI), London. Retrieved June 20, 2019, from https://www.alz.co.uk/research/WorldAlzheimerReport2018.pdf.

Paul, K., & Bhattacharjee, P. (2018). Process optimization of supercritical carbon dioxide extraction of 1,8-cineole from small cardamom seeds by response surface methodology: In vitro antioxidant, antidiabetic and hypocholesterolemic activities of extracts. Journal of Essential Oil Bearing Plants,21(2), 317–329. https://doi.org/10.1080/0972060X.2018.1439406.CrossRef

Poddar, J., Pradhan, M., Ganguly, G., & Chakrabarti, S. (2019). Biochemical deficits and cognitive decline in brain aging: Intervention by dietary supplements. Journal of Chemical Neuroanatomy,95, 70–80. https://doi.org/10.1016/j.jchemneu.2018.04.002.CrossRefPubMed

Reitz, C. (2012). Alzheimer’s disease and the amyloid cascade hypothesis: A critical review. International Journal of Alzheimer’s Disease,2012, 1–11. https://doi.org/10.1155/2012/369808.CrossRef

Schulz, V. (2003). Ginkgo extract or cholinesterase inhibitors in patients with dementia: What clinical trials and guidelines fail to consider. Phytomedicine,10(4), 74–79. https://doi.org/10.1078/1433-187X-00302.CrossRefPubMed

Serrano-Pozo, A., Frosch, M. P., Masliah, E., & Hyman, B. T. (2011). Neuropathological alterations in Alzheimer disease. Cold Spring Harbor Perspectives in Medicine,1(1), 1–23. https://doi.org/10.1101/cshperspect.a006189.CrossRef

Sinha, M., Bhowmick, P., Banerjee, A., & Chakrabarti, S. (2013). Antioxidant role of amyloid β-protein in cell-free and biological systems: Implication for the pathogenesis of Alzheimer disease. Free Radical Biology & Medicine,56, 184–192. https://doi.org/10.1016/j.freeradbiomed.2012.09.036.CrossRef

Smith, M. A., Rottkamp, C. A., Nunomura, A., Raina, A. K., & Perry, G. (2000). Oxidative stress in Alzheimer’s disease. Biochimica et Biophysica Acta,1502(1), 139–144. https://doi.org/10.1016/S0925-4439(00)00040-5.CrossRefPubMed

Stein, S. E. (2007). Mass Spectra. Mallard Gaithersburg NIST Chemistry Web Book. In: P. Linstrom, W.G. Mallard (Eds.), NIST Standard Reference Database Number 69, National Institute of Standards and Technology, Gaithersburg, MD, USA. Retrieved 2 June, 2018, from http://webbbok.nist.gov.

Stoothoff, W. H., & Johnson, G. V. (2005). Tau phosphorylation: Physiological and pathological consequences. Biochimica et Biophysica Acta,1739(2–3), 280–297. https://doi.org/10.1016/j.bbadis.2004.06.017.CrossRefPubMed

Suntar, I., Khan, H., Patel, S., Celano, R., & Rastrelli, L. (2018). An Overview on Citrus aurantium L.: Its functions as food ingredient and therapeutic agent. Oxidative Medicine and Cellular Longevity,2018, 1–12. https://doi.org/10.1155/2018/7864269.CrossRef

Swerdlow, R. H. (2007). Pathogenesis of Alzheimer’s disease. Clinical Interventions in Aging,2(3), 347–359.PubMedPubMedCentral

Ward, J. R., Zucca, A. F., Duyn, H. J., Crichton, R. R., & Zecca, L. (2014). The role of iron in brain ageing and neurodegenerative disorders. The Lancet Neurology,13(10), 1045–1060. https://doi.org/10.1016/S1474-4422(14)70117-6.CrossRefPubMedPubMedCentral

Wyss-Coray, T., & Rogers, J. (2012). Inflammation in Alzheimer disease-a brief review of the basic science and clinical literature. Cold Spring Harbor Perspectives in Medicine,2(1), 1–23. https://doi.org/10.1101/cshperspect.a006346.CrossRef

Yiannopoulou, K. G., & Papageorgiou, S. G. (2013). Current and future treatments for Alzheimer’s disease. Therapeutic Advances in Neurological Disorders,6(1), 19–33. https://doi.org/10.1177/1756285612461679.CrossRefPubMedPubMedCentral

Zheng, H., Amit, T., Bar-Am, O., Fridkin, M., Youdim, M. B. H., & Mandel, S. A. (2012). From anti-Parkinson’s drug rasagiline to novel multitarget iron chelators with acetylcholinesterase and monoamine oxidase inhibitory and neuroprotective properties for Alzheimer’s disease. Journal of Alzheimer’s Disease,30(1), 1–16. https://doi.org/10.3233/JAD-2012-120013.CrossRefPubMed

Titel: Is 1,8-Cineole-Rich Extract of Small Cardamom Seeds More Effective in Preventing Alzheimer’s Disease than 1,8-Cineole Alone?
verfasst von: Kaninika Paul
Upasana Ganguly
Sasanka Chakrabarti
Paramita Bhattacharjee
Publikationsdatum: 18.10.2019
Verlag: Springer US
Erschienen in: NeuroMolecular Medicine / Ausgabe 1/2020
Print ISSN: 1535-1084
Elektronische ISSN: 1559-1174
DOI: https://doi.org/10.1007/s12017-019-08574-2

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Neurologie

23.04.2024 | Demenz | Nachrichten

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Is 1,8-Cineole-Rich Extract of Small Cardamom Seeds More Effective in Preventing Alzheimer’s Disease than 1,8-Cineole Alone?

Abstract

Leitlinien kompakt für die Neurologie

Neu im Fachgebiet Neurologie

Demenzkranke durch Antipsychotika vielfach gefährdet

Parkinson-Therapie im Wandel – aktuelle Leitlinie im Fokus

Auf diese Krankheiten bei Geflüchteten sollten Sie vorbereitet sein

Hustenstiller lindert Agitation bei Alzheimer

Update Neurologie

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 1/2020

Association of HSPA1B Polymorphisms with Paranoid Schizophrenia in a Polish Population

Driving Neurogenesis in Neural Stem Cells with High Sensitivity Optogenetics

The Putative Association of TOB1-AS1 Long Non-coding RNA with Immune Tolerance: A Study on Multiple Sclerosis Patients

CSF sAPPα and sAPPβ levels in Alzheimer’s Disease and Multiple Other Neurodegenerative Diseases: A Network Meta-Analysis

RIP at the Synapse and the Role of Intracellular Domains in Neurons

Mucopolysaccharidosis and Autophagy: Controversies on the Contribution of the Process to the Pathogenesis and Possible Therapeutic Applications

Leitlinien kompakt für die Neurologie

Neu im Fachgebiet Neurologie

Demenzkranke durch Antipsychotika vielfach gefährdet

Parkinson-Therapie im Wandel – aktuelle Leitlinie im Fokus

Auf diese Krankheiten bei Geflüchteten sollten Sie vorbereitet sein

Hustenstiller lindert Agitation bei Alzheimer

Update Neurologie